• Asian Pacific Journal of Cancer Prevention
• /
• 제15권1호
• /
• pp.433-439
• /
• 2014

We attempted to develop an indicator combining incidence with mortality rates (single measure of cancer burden, SMCB) and to compare the magnitudes of cancer burden by world region. The SMCB was used to measure the size of cancer burden summarizing the incidence and mortality. The incidence and mortality were divided in equivalent forms and were split. The criteria dividing the size of cancer burden were used as the maximum incidence and mortality by men and women according to the world database, and the value corresponding to 10% of each maximum was set as the cut-off value. In SMCB, the size of cancer burden was highest for men with lung cancer (SMCB=18) and for women with breast cancer (SMCB=14) in MDR (more developed regions) compared to the size of burden in LDR (lower developed regions) (lung, SMCB=11, breast, SMCB=8). For men, the size of cancer burden by region was highest in EURO (SMCB=18, lung), followed by WPRO (SMCB=16, lung), PAHO (SMCB=14, prostate), AFRO (SMCB=8, prostate) and SEARO (SMCB=7, lung). Moreover, for women, the size of cancer burden was greatest in EURO (SMCB=14, breast), followed by PAHO (SMCB=13, breast), AFRO (SMCB=11, cervix uteri), EMRO (SMCB=9, breast) or SEARO (SMCB=8, cervix uteri) and WPRO (SMCB=7, lung). The summary indicator will help to provide a priority setting for reducing cancer burden in health policy.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권9호
• /
• pp.5249-5255
• /
• 2013

Background: The purpose of this study was to develop a single measure of cancer burden (SMCB), which can prioritize cancer sites by considering incidence and mortality. Materials and Methods: Incidence data from 1999 to 2010 were obtained from the Korea Central Cancer Registry. Mortality data from 1999 to 2010 were obtained from Statistics Korea. The SMCB was developed by adding incidence and mortality scores. The respective scores were given such that incidence and mortality were classified by ten ranges of equal intervals. Results: According to the SMCB in 2010, stomach cancer ranked $1^{st}$ in males with 20 points, and colorectal cancer was $2^{nd}$ with 11 points. Breast cancer and thyroid cancer were joint $1^{st}$ with 11 points for females. The SMCB for females was less than that for males. The burden of stomach cancer was $1^{st}$ in males from 1999-2010. The incidences of lung cancer and liver cancer decreased, whereas thyroid cancer and colon cancer increased during the period. Breast cancer and thyroid cancer burden showed tendencies to increase in females. Comparison of SMCB with disability-adjusted life years (DALY) and socioeconomic costs in 2005 showed that the top five cancer sites were similar, but there were differences in the size of the cancer burden. Conclusions: The SMCB indicated that the burdens of stomach cancer in males and thyroid and breast cancers in females were large. The single measure showed an advantage, reflected as the equivalent dimensions of incidence and mortality, whereas DALY and economic costs showed tendencies to reflect premature death.

• 한국방사선학회논문지
• /
• 제17권1호
• /
• pp.167-173
• /
• 2023

일반 X-선 검사는 간단하고 많은 정보를 얻을 수 있어 가장 기본이 되는 검사방법이며 획득된 영상에서는 인체 해부학적 구조와 시간 경과에 따른 질병의 변화 정보를 쉽게 획득할 수 있다. 그럼에도 불구하고 영상이 확대되는 단점으로 인하여 병변의 크기와 형태가 왜곡되어 나타나기 때문에 현재 X-선 영상의 깊이 있는 관찰은 이루어지지 않고 있다. 본 연구에서는 후전촬영(PA)과 측방향촬영(LAT) 영상을 획득하고 각각의 영상에서 암 시료가 위치하는 거리를 측정하여 암 시료의 확대율을 계산하고 측정한 암 시료 길이에 보정한다. 암 시료의 길이와 두께에 따른 확대율 보정 값을 전산화단층촬영장치(Computed Tomography, CT)로 획득된 영상 및 실제 제작한 암 시료 크기와 각각 비교하였다. 기존의 확대율은 검출기에서 암의 거리를 측정하여 계산할 수 있었으나 본 연구에서는 획득된 PA와 LAT 영상을 이용하여 확대율을 계산하였다. 6 mm 암 시료를 PA와 LAT 영상을 획득하여 확대율을 구한 후 보정한 결과 길이는 5.9 mm, 두께는 6.1mm로 실제와 비슷한 값이 측정되었으며 영상을 이용한 확대율 계산이 가능하다는 것을 알 수 있었다. X-선 영상만으로도 병변의 확대율을 손쉽게 보정하여 정확한 길이 측정이 가능하고 이는 영상 판독 및 정확한 진단에 유용한 정보를 제공할 것이다.

• 한국멀티미디어학회논문지
• /
• 제23권5호
• /
• pp.625-632
• /
• 2020

In the diagnosis of lung cancer, the tumor size is measured by the longest diameter of the tumor in the entire slice of the CT. In order to accurately estimate the size of the tumor, it is better to measure the volume, but there are some limitations in calculating the volume in the clinic. In this study, we propose an algorithm to segment lung cancer by applying a custom loss function that combines focal loss and dice loss to a U-Net model that shows high performance in segmentation problems in chest CT images. The combination of values of the various parameters in custom loss function was compared to the results of the model learned. The purposed loss function showed F1 score of 88.77%, precision of 87.31%, recall of 90.30% and average precision of 0.827 at α=0.25, γ=4, β=0.7. The performance of the proposed custom loss function showed good performance in lung cancer segmentation.

• 대한핵의학회지
• /
• 제36권1호
• /
• pp.34-38
• /
• 2002

Positron emission tomography(PET) is an imaging method that employs radionuclide and tomography techniques. Since 1995, we applied PET not only to the diagnosis of breast cancer but also to the detection of abnormalities in the augmented breast and to the detection of metastasis. Until 2001, we evaluated 242 breast cases by PET at PET center of Seoul National University Hospital. Our group has reported serially at the international journals. In the first report, PET showed high sensitivity for detecting breast cancer, both the primary and axillary node metastasis. A total of 27 patients underwent breast operations based on PET results at Seoul National University Hospital from 1995 to 1996. The diagnostic accuracy of PET were 97% for the primary tumor mass and 96% for axillary lymph node metastasis. In case of the breast augmented, PET also showed excellent diagnostic results for primary breast cancer and axillary lymph node metastasis where mammography and ultrasound could not diagnose properly. PET also had outstanding results in the detection of recurrent or metastatic breast cancer(sensitivity 94%, specificity 80%, accuracy 89%). In addition, our study gave some evidence that PET could be applied further to evaluate the growth rate of tumors by measuring SUV, and finally to prognosticated the disease. PET could also be applied to evaluate the response after chemotherapy to measure its metabolic rate and size. In conclsion, PET is a highly sensitive, accurate diagnostic tool for breast cancer of primary lesion in various conditions including metastasis.

• 대한방사선치료학회지
• /
• 제18권1호
• /
• pp.1-5
• /
• 2006

목 적: 세기조절 방사선치료의 환자별 정도관리는 이온전리함을 이용한 일정 지점에서의 절대 선량 측정과 필름을 이용한 상대 선량측정의 두 단계로 구성된다. 이온전리함을 이용한 절대 선량 측정은 동일한 지점에서 치료계획상의 점선량과 실제 측정 점선량 간의 일치도에 대한 정보를 제공한다. 일반적으로 정확한 점선량을 측정하기 위해 volume이 작은 0.015 cc 이온전리함(pin point chamber, PTW, Germany)을 사용하고 있다. 그러나 이 경우 이온전리함의 볼륨이 작아 선량의 오차가 크게 나타나는 경우도 있어, 적합한 볼륨의 이온전리함 사용이 권고되기도 한다. 따라서 볼륨이 다른 세 가지의 이온전리함을 이용하여 점선량을 측정하여 치료계획상의 점 선량과 비교해 보고, 0.015 cc 이온전리함을 이용한 세기조절 방사선치료에서의 절대 점선량 측정의 유효성을 평가해 보고자 한다. 대상 및 방법: 두경부(Head & Neck) 종양의 세기조절 방사선치료가 요구되는 환자 6명을 대상으로 Sliding-window 방법의 IMRT 치료계획을 수립하였으며 치료기는 21EX(Varian, USA) 선형가속기의 6 MV 광자선을 사용하였다. 측정 조건은 120 millenium MLC를 이용하여 Gantry 0도에서 300 MU/min의 선량률로 선원-이온전리함(source-axis-distance)거리를 100 cm, 고체팬텀의 표면으로부터 5 cm 깊이에 이온전리함을 위치시켰다. 치료계획용 컴퓨터(CAD-Plan, USA)에서 결정된 결과를 0.015 cc(pin point, type 31014, PTW, Germany), 0.125 cc(micro type 31002, PTW, Germany ), 0.6 cc(famer type 30002, PTW, Germany) 전리함에 각각 조사하여 측정치를 비교 분석하였다. 측정점은 선량값의 변화가 상대적으로 적은 선량 저변동 영역(Low-gradient area)에 위치시켰다. 결 과: 각각의 이온전리함을 이용하여 측정한 결과 0.015 cc의 경우 평균 ${\pm}0.91%$, 0.125 cc의 경우 ${\pm}0.52%$, 0.6 cc의 경우 ${\pm}0.76%$로 0.125 cc 이온전리함의 경우가 모든 측정조건에서 가장 적은 오차를 보였다. 결 론: 세기조절 방사선치료에 있어서 선량의 평가는 매우 중요하다. 방사선치료가 정밀해지는 만큼 정확한 선량평가가 이루어져야 한다. 점선량을 평가하기 위해 제작된 0.015 cc 이온전리함은 작은 출력신호와 큰 신호 대 잡음비가 절대 선량 측정 시 선량오차를 발생시키는 큰 요인으로 작용할 수 있다. 반면에 이온전리함의 볼륨이 큰 경우 출력신호가 크므로 정확한 선량을 반영할 수 있으나, 작은 측정점에 이온전리함을 정확히 위치시키기 어려워 절대 점선량을 측정하기 어려운 단점이 있다. 따라서 본 연구의 결과에서 본 바와 같이 세기조절 방사선치료의 절대 점선량 측정에는 오차가 상대적으로 적은 0.125 cc 이온전리함의 사용이 고려되어야 한다.

• 한국방사선학회논문지
• /
• 제14권5호
• /
• pp.523-528
• /
• 2020

반려견의 사망원인 1위인 암 중 암컷에게서 가장 높은 발생률을 보이는 유방암을 대상으로 근접방사선치료 수행 시 모의모사를 이용한 흡수선량 측정을 바탕으로 적용성을 평가하고자 하였다. 모의모사를 위해 MCNPX 프로그램을 이용하였으며, 흡수선량 측정을 위해 소형견 크기의 수학적 팬텀을 제작 하였다. 흡수선량 측정결과 종양의 경우 ¹⁹²Ir에서 1.02E-12 Gy/#으로 흡수선량이 가장 높은 것으로 나타났으며, 내·외부 흡수선량에서도 동일한 경향성으로 나타났다. 따라서 반려견 유방암의 근접방사선치료 시 견종과 피폭을 고려한 적절한 선원의 선택이 고려되어야 될 것이다.

• 혜화의학회지
• /
• 제15권1호
• /
• pp.41-45
• /
• 2006

Aims: This overview summarizes the existing evidence on acupuncture for cancer-related pain. Methods: Literature searches were conducted in 7 databases. All clinical studies of acupuncture, electroacupuncture, ear acupuncture and transcutaneous electrical nerve stimulation (TENS) in cancer patients with the main outcome measure of pain were included. Results: Of the 8 studies included, one high quality randomized clinical trial (RCT) of ear acupuncture showed statistically significant pain relief in comparison with placebo ear acupuncture. All the other studies were either non-blinded (n = 2) or uncontrolled clinical trials (n = 5). Most investigations suffered from methodological flaws such as inadequate study design, poor reporting of results, small sample size and overestimation of the results. Conclusions: The current evidence does not support the use of acupuncture as an adjunctive analgesic method for cancer patients. Only one high quality RCT showed promising results thus warranting further investigation into this under-researched area.

• 한국의학물리학회:학술대회논문집
• /
• 한국의학물리학회 2002년도 Proceedings
• /
• pp.231-232
• /
• 2002

We have been developing microvolume LET counter in order to measure the three-dimensional LET distribution of the therapeutic heavy ion radiation volumes in the water phantom. With help of the technique of cathode induced carhge readout, this detector has a rectangular (box-shape) sensitive volume of which size is about 1 mm$^2$ and 2mm (depth).

• Journal of Digestive Cancer Research
• /
• 제10권1호
• /
• pp.1-8
• /
• 2022

The incidence of gastric neuroendocrine tumors (NET) has been increased with the improvement of endoscopy accessibility. The World Health Organization classified NET of low (G1), intermediate (G2), high (G3) grade and neuroendocrine carcinoma with poor differentiation by mitotic count and Ki-67 labeling index. Gastric NET are divided into three subtypes based on the pathophysiology, and treatment is determined according to the subtype and prognostic factors of tumor. For diagnosis, endoscopy with biopsy, endoscopic ultrasonography, abdominal pelvis computed tomography, and serum gastrin level measure are required. In general, type 3, size > 2 cm, deep submucosal infiltration, high histological grade, lymphovascular invasion and metastasis are poor prognostic factors. Type 1 or 2 without these factors are treated by endoscopic resection, and other tumors needs surgery. Endoscopic resection of early type 3 or type 1 and 2 tumors with poor prognostic factors still remains a challenge.